ChineseInvestors.com, Inc. (CIIX) Shares Big News Regarding CBD Products and Spin-off
- Industrial hemp to be removed from the list of controlled substances under U.S. federal law
- Proposed licensing agreement with VitaMist for exclusive rights in the global Asian market for a new sprayable vitamin and vitamin/CBD product line
- Company recently announced the appointment of a chief financial officer of CBD Biotech, its CBD spin-off and wholly owned subsidiary
ChineseInvestors.com, Inc. (OTCQB: CIIX), the premier financial information website for Chinese-speaking investors, is increasingly enthusiastic about the unique role it is playing within the cannabis industry as laws change globally.
The Agriculture Improvement Act of 2018, also known as the farm bill, recently passed in the United States House of Representatives and the Senate. It was also signed by President Trump (http://nnw.fm/pR4Yl). This bill includes Sen. Majority Leader Mitch McConnell’s Hemp Farming Act, which removes industrial hemp from the list of controlled substances under federal law. This is good news for CIIX, which recognized the opportunities in the U.S. early on. The company has offices located in the U.S. and China, representing a key link between the U.S. and global Chinese community, and it is working on creating additional CBD products in nutrition and cosmetics.
In addition to the changing laws in the United States, CIIX is excited about its new ventures. In a recent press release (http://nnw.fm/0EaCH), the company announced its intent to enter into a licensing agreement with VitaMist Ltd.
In 1985, VitaMist was awarded the first patent ever for a spray vitamin and has established itself over the years as a recognized brand with over three million individual product sales. Its innovative spray technology, brand recognition, 30 years in the industry and 40+ proprietary vitamin formulas represent a significant addition to CIIX as the company expands product lines globally. “We truly believe,” CIIX CEO Warren Wang stated in a news release, “VitaMist’s innovative and effective delivery system is the future for CBD consumption.”
VitaMist CEO Richard Heineck is equally optimistic regarding the upcoming new sprayable vitamin and vitamin/CBD product line that will be designed exclusively for CIIX and the global Asian market, referring to the proposed licensing agreement as a “grand slam!” VitaMist’s delivery system and precise dosing methodology and CIIX’s focus on the Asian consumer market all play into making these two companies a promising pair.
Wang expressed excitement at being a part of expanding reach into the global industrial hemp industry. The company’s ties to the Asian consumer market are strong, and, with South Korea becoming the first East Asian country to legalize marijuana for medical purposes, Wang is hopeful that Thailand will soon follow.
The company is one step closer in the process of spinning off its CBD division through the appointment of new leadership. Alex Hamilton has been appointed to the position of chief financial officer of CIIX’s wholly owned subsidiary, CBD Biotechnology, Ltd. (http://nnw.fm/zK4WB). Hamilton joins Summer Yun, CEO of CBD Biotech. Hamilton has been appointed to oversee the spin-off of the CBD division under the guidance of Wang, freeing CIIX to refocus on its core financial services and media business.
CIIX is a leading financial information website for Chinese-speaking investors throughout the United States, Canada and China. The company is laying the groundwork to capitalize on the growing demand for CBD-based nutrition and health products. The development of new product lines with VitaMist is only a small part of a much larger, globally-focused business plan.
For more information, visit the company’s website at www.ChineseInvestors.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Industrial hemp to be removed from the list of controlled substances under U.S. federal law
- Proposed licensing agreement with VitaMist for exclusive rights in the global Asian market for a new sprayable vitamin and vitamin/CBD product line
- Company recently announced the appointment of a chief financial officer of CBD Biotech, its CBD spin-off and wholly owned subsidiary
ChineseInvestors.com, Inc. (OTCQB: CIIX), the premier financial information website for Chinese-speaking investors, is increasingly enthusiastic about the unique role it is playing within the cannabis industry as laws change globally.
The Agriculture Improvement Act of 2018, also known as the farm bill, recently passed in the United States House of Representatives and the Senate. It was also signed by President Trump (http://nnw.fm/pR4Yl). This bill includes Sen. Majority Leader Mitch McConnell’s Hemp Farming Act, which removes industrial hemp from the list of controlled substances under federal law. This is good news for CIIX, which recognized the opportunities in the U.S. early on. The company has offices located in the U.S. and China, representing a key link between the U.S. and global Chinese community, and it is working on creating additional CBD products in nutrition and cosmetics.
In addition to the changing laws in the United States, CIIX is excited about its new ventures. In a recent press release (http://nnw.fm/0EaCH), the company announced its intent to enter into a licensing agreement with VitaMist Ltd.
In 1985, VitaMist was awarded the first patent ever for a spray vitamin and has established itself over the years as a recognized brand with over three million individual product sales. Its innovative spray technology, brand recognition, 30 years in the industry and 40+ proprietary vitamin formulas represent a significant addition to CIIX as the company expands product lines globally. “We truly believe,” CIIX CEO Warren Wang stated in a news release, “VitaMist’s innovative and effective delivery system is the future for CBD consumption.”
VitaMist CEO Richard Heineck is equally optimistic regarding the upcoming new sprayable vitamin and vitamin/CBD product line that will be designed exclusively for CIIX and the global Asian market, referring to the proposed licensing agreement as a “grand slam!” VitaMist’s delivery system and precise dosing methodology and CIIX’s focus on the Asian consumer market all play into making these two companies a promising pair.
Wang expressed excitement at being a part of expanding reach into the global industrial hemp industry. The company’s ties to the Asian consumer market are strong, and, with South Korea becoming the first East Asian country to legalize marijuana for medical purposes, Wang is hopeful that Thailand will soon follow.
The company is one step closer in the process of spinning off its CBD division through the appointment of new leadership. Alex Hamilton has been appointed to the position of chief financial officer of CIIX’s wholly owned subsidiary, CBD Biotechnology, Ltd. (http://nnw.fm/zK4WB). Hamilton joins Summer Yun, CEO of CBD Biotech. Hamilton has been appointed to oversee the spin-off of the CBD division under the guidance of Wang, freeing CIIX to refocus on its core financial services and media business.
CIIX is a leading financial information website for Chinese-speaking investors throughout the United States, Canada and China. The company is laying the groundwork to capitalize on the growing demand for CBD-based nutrition and health products. The development of new product lines with VitaMist is only a small part of a much larger, globally-focused business plan.
For more information, visit the company’s website at www.ChineseInvestors.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
